Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/20/1996 | WO1996018734A1 Production of recombinant secretory component |
06/20/1996 | WO1996018733A2 Ribozyme-mediated inactivation of leukemia-associated rna |
06/20/1996 | WO1996018732A2 Sequence-specific inhibition of dna synthesis by triplex-forming oligonucleotides |
06/20/1996 | WO1996018730A1 Prostatic growth factor |
06/20/1996 | WO1996018726A1 Compositions and methods for stimulating hematopoietic cell expansion |
06/20/1996 | WO1996018725A1 Human tissue inhibitor of metalloproteinase-4 |
06/20/1996 | WO1996018654A1 Factor vii fragment 82-128 and its use in blood-clotting disorders |
06/20/1996 | WO1996018653A1 Disulphide-cyclo-[h-cys-glu-gln-tyr-cys-oh], and its use in blood-clotting disorders |
06/20/1996 | WO1996018652A1 Hexapeptides possessing antitumor activity |
06/20/1996 | WO1996018651A1 Human somatostatin-like receptor |
06/20/1996 | WO1996018650A1 Novel receptor |
06/20/1996 | WO1996018649A1 Improved cyclic crf agonists |
06/20/1996 | WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
06/20/1996 | WO1996018647A1 Spray dried erythropoietin |
06/20/1996 | WO1996018646A2 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
06/20/1996 | WO1996018644A1 Aromatic heterocyclic derivatives as enzyme inhibitors |
06/20/1996 | WO1996018643A1 Tachykinin antagonists |
06/20/1996 | WO1996018642A1 Amino acids for making betides and methods of screening and making betide libraries |
06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
06/20/1996 | WO1996018640A1 Antisense nucleic acid homolog |
06/20/1996 | WO1996018639A1 Novel protein tyrosine kinase, jak3 |
06/20/1996 | WO1996018627A1 Ahpba-containing tripeptide derivative |
06/20/1996 | WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
06/20/1996 | WO1996018418A1 Improved adenoviral vectors and producer cells |
06/20/1996 | WO1996018417A1 Crystalline protein controlled release compositions |
06/20/1996 | WO1996018414A1 Acellular anti-bordetella vaccine |
06/20/1996 | WO1996018413A1 Carcinoma treatment |
06/20/1996 | WO1996018412A1 Chimeric cytokines and uses thereof |
06/20/1996 | WO1996018411A1 Localized delivery of factors enhancing survival of transplanted cells |
06/20/1996 | WO1996018410A1 Agent for treating primary liver cancer and a method of treating primary liver cancer |
06/20/1996 | WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells |
06/20/1996 | WO1996018408A1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
06/20/1996 | WO1996018402A1 Cobalt schiff base compounds |
06/20/1996 | WO1996018313A1 Increasing creatine and glycogen concentration in muscle |
06/20/1996 | WO1996015234A3 Lipid-splitting enzyme |
06/20/1996 | WO1996013286A3 Modulation of cell proliferation and wound healing |
06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
06/20/1996 | WO1996003993A3 Modulation of thymocyte and t cell functional activity |
06/20/1996 | WO1996002276A3 Novel polymer gel networks and methods of use |
06/20/1996 | DE4445317A1 Topical compsns. contg. hirudin or heparin |
06/20/1996 | DE4444753A1 Prodn. of casein-alpha-s2 peptide(s) with antibiotic activity |
06/20/1996 | CA2207921A1 Novel receptor |
06/20/1996 | CA2207748A1 Cobalt schiff base compounds |
06/20/1996 | CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells |
06/20/1996 | CA2207626A1 Novel protein tyrosine kinase, jak3 |
06/20/1996 | CA2207593A1 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses |
06/20/1996 | CA2207576A1 Improved cyclic crf agonists |
06/20/1996 | CA2206683A1 Improved adenoviral vectors and producer cells |
06/20/1996 | CA2206669A1 Human tissue inhibitor of metalloproteinase-4 |
06/20/1996 | CA2206400A1 Aromatic heterocyclic derivatives as enzyme inhibitors |
06/20/1996 | CA2206258A1 Amino acids for making betides and methods of screening and making betide libraries |
06/20/1996 | CA2205572A1 Chimeric cytokines and uses thereof |
06/20/1996 | CA2204130A1 Tachykinin antagonists |
06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
06/19/1996 | EP0717110A1 LGMD gene |
06/19/1996 | EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
06/19/1996 | EP0717048A1 Cyclic hexapeptides and their mixings, process to synthesize them and their use |
06/19/1996 | EP0716710A1 Methods of suppressing immune response by gene therapy |
06/19/1996 | EP0716701A1 Cloning of a member of the serine-threonine-kinase family |
06/19/1996 | EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
06/19/1996 | EP0716694A1 Human glucagon-like 1 peptide receptor |
06/19/1996 | EP0716692A1 Methods of suppressing autoimmune response |
06/19/1996 | EP0716691A1 Methods of suppressing graft rejection |
06/19/1996 | EP0716662A1 Dna encoding prostaglandin receptor ep2 |
06/19/1996 | EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists |
06/19/1996 | EP0716660A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
06/19/1996 | EP0716659A1 Epiligrin, an epithelial ligand for integrins |
06/19/1996 | EP0716658A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |
06/19/1996 | EP0716614A1 Treatment of human tumors by genetic transformation of human tumor cells |
06/19/1996 | EP0716611A1 Method to reduce myocardial injury during acute myocardial infarction |
06/19/1996 | EP0716610A1 Neural regeneration using human bone morphogenetic proteins |
06/19/1996 | EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY |
06/19/1996 | EP0716604A1 Thiol-derivatized nucleosides and oligonucleosides |
06/19/1996 | EP0716591A1 METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS |
06/19/1996 | EP0621899B1 Expression signal-peptide-free staphylokinases |
06/19/1996 | EP0605504B1 Cosmetic and dermatological preparations |
06/19/1996 | EP0580817B1 Pharmaceutical formulation and process |
06/19/1996 | EP0563134B1 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
06/19/1996 | EP0535192B1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same |
06/19/1996 | EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor |
06/19/1996 | EP0516851B1 Physiologically active substance well capable of permeating biomembrane |
06/19/1996 | EP0506923B1 A collagen binding protein as well as its preparation |
06/19/1996 | EP0495852B1 Modified biological material |
06/19/1996 | EP0489089B1 Therapeutic peptides |
06/19/1996 | EP0418310B1 Gene for encoding a human malaria vaccine antigen |
06/19/1996 | CN1124964A Trifunctional antithrombin and antiplatelet peptides |
06/19/1996 | CN1124929A Novel agent for controlling cell activity |
06/19/1996 | CN1124927A Analogs of peptide YY and uses thereof |
06/19/1996 | CN1124779A Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of IRF-1-spectific RNA in biopsy samples |
06/19/1996 | CN1124739A Vaccin peptide of blood fluke |
06/19/1996 | CN1124656A Medicinal biological response regulating agent of cooperative polysaccharide modification |
06/19/1996 | CN1124617A Lyophilized bougie and producing process thereof |
06/18/1996 | USRE35277 Cell membrane proteins, compositions containing them and procedure for their preparation |
06/18/1996 | US5527897 Genetic engineering |
06/18/1996 | US5527884 Mediators of chronic allograft rejection and DNA molecules encoding them |
06/18/1996 | US5527881 Procedure for preparing salmon calcitonin |
06/18/1996 | US5527856 Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
06/18/1996 | US5527807 Treating alopecia, acne, prostate disorders |
06/18/1996 | US5527795 Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
06/18/1996 | US5527778 Method for selective opening of abnormal brain tissue capillaries |